Brief: Mankind Pharma Says Remaining 56.31% Shares Of Bharat Serums And Vaccines Pledged In Favour Of Catalyst Trusteeship
07/01/2025 14:32
Jan 7 (Reuters) - Mankind Pharma Ltd MNKI.NS :
* REMAINING 56.31% SHARES OF BHARAT SERUMS AND VACCINES
PLEDGED IN
FAVOUR OF CATALYST TRUSTEESHIP
Source text: ID:nBSE4Hw2Y5
Further company coverage: MNKI.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery